Do nutrients and nutraceuticals play a role in diabetic retinopathy? A systematic review
A Milluzzo, M Barchitta, A Maugeri, R Magnano San Lio… - Nutrients, 2022 - mdpi.com
Diabetic retinopathy (DR) is a multifactorial neuro-microvascular disease, whose prevalence
ranges from 25% to 60% of subjects affected by diabetes mellitus, representing the main …
ranges from 25% to 60% of subjects affected by diabetes mellitus, representing the main …
AAV-based strategies for treatment of retinal and choroidal vascular diseases: advances in age-related macular degeneration and diabetic retinopathy therapies
Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vascular
diseases with high prevalence, ranking among the leading causes of blindness and vision …
diseases with high prevalence, ranking among the leading causes of blindness and vision …
Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
J Zhang, D Sharma, A Dinabandhu… - The Journal of …, 2023 - Am Soc Clin Investig
Many patients with diabetic eye disease respond inadequately to anti-VEGF therapies,
implicating additional vasoactive mediators in its pathogenesis. We demonstrate that levels …
implicating additional vasoactive mediators in its pathogenesis. We demonstrate that levels …
[HTML][HTML] Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration
Diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD)
are multifactorial disorders that affect the macula and cause significant vision loss. Although …
are multifactorial disorders that affect the macula and cause significant vision loss. Although …
CD40 upregulation in the retina of patients with diabetic retinopathy: Association with TRAF2/TRAF6 upregulation and inflammatory molecule expression
S Vos, R Aaron, M Weng, J Daw… - … & Visual Science, 2023 - iovs.arvojournals.org
Purpose: CD40 is upregulated in the retinas of diabetic mice, drives pro-inflammatory
molecule expression, and promotes diabetic retinopathy. The role of CD40 in diabetic …
molecule expression, and promotes diabetic retinopathy. The role of CD40 in diabetic …
[HTML][HTML] Aflibercept combined with triamcinolone acetonide in the treatment of diabetic macular edema: optical coherence tomography and optical coherence …
DS Li, HX Liao, CH Zhang, JG Huang… - International Journal …, 2024 - ncbi.nlm.nih.gov
AIM To analyze the relationship between optical coherence tomography (OCT) and OCT
angiography (OCTA) imaging in patients with diabetic macular edema (DME) who are …
angiography (OCTA) imaging in patients with diabetic macular edema (DME) who are …
[PDF][PDF] Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review.
A Milluzzo, M Barchitta, A Maugeri, R Magnano San Lio… - Nutrients, 2022 - iris.unict.it
Diabetic retinopathy (DR) is a multifactorial neuro-microvascular disease, whose prevalence
ranges from 25% to 60% of subjects affected by diabetes mellitus, representing the main …
ranges from 25% to 60% of subjects affected by diabetes mellitus, representing the main …
Systemic administration of pegylated arginase-1 attenuates the progression of diabetic retinopathy
AA Abdelrahman, KL Bunch, PV Sandow, PNM Cheng… - Cells, 2022 - mdpi.com
Diabetic retinopathy (DR) is a serious complication of diabetes that results from sustained
hyperglycemia, hyperlipidemia, and oxidative stress. Under these conditions, inducible nitric …
hyperglycemia, hyperlipidemia, and oxidative stress. Under these conditions, inducible nitric …